![Raymond Francot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raymond Francot
Chief Executive Officer at Myriad Service GmbH
Network origin in Raymond Francot first degree
Entity | Entity type | Industry | |
---|---|---|---|
Myriad GmbH
![]() Myriad GmbH Medical/Nursing ServicesHealth Services Part of Myriad Genetics, Inc., Myriad GmbH is a German company that provides health care services. The company is based in Munich, Germany. The CEOs of the company are Nathan Alan Smith, Peter D. Meldrum, Raymond Francot.
2
| Subsidiary | Medical/Nursing Services | 2 |
Myriad Service GmbH
![]() Myriad Service GmbH Medical/Nursing ServicesHealth Services Part of Myriad Genetics, Inc., Myriad Service GmbH provides healthcare services. The company is based in Planegg, Germany. The CEOs of the German company are Nathan Man Smith, Raymond Francot.
1
| Subsidiary | Medical/Nursing Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Raymond Francot via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MYRIAD GENETICS, INC. | Medical Specialties | Founder Investor Relations Contact | |
The Founders Fund, Inc.
![]() The Founders Fund, Inc. Miscellaneous Commercial ServicesCommercial Services The Founders Fund, Inc. provides financial assistance to students. It offers scholarships and sponsoring solutions to students for them to defray the cost of attending colleges, universities, and professional programs. The company was founded in 1991 and is headquartered in Naples, FL. | Miscellaneous Commercial Services | President | |
SINTX TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
University of Utah | College/University | Masters Business Admin | |
Westminster College (Utah) | College/University | Doctorate Degree | |
Prolexys Pharmaceuticals, Inc.
![]() Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Pharmaceuticals: Major | Director/Board Member | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Myriad Genetics GmbH
![]() Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Myriad Genetics GmbH provides clinical diagnostic test services. It specializes in generic testing and disease diagnostic services. The company is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
United States | 8 |
Switzerland | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Operational
Chief Executive Officer | 5 |
Director/Board Member | 4 |
President | 2 |
Doctorate Degree | 2 |
Founder | 1 |
Most connected contacts
Insiders | |
---|---|
Peter D. Meldrum | 8 |
Nathan Alan Smith | 3 |
Nathan Man Smith | 1 |
- Stock Market
- Insiders
- Raymond Francot
- Company connections